This study aims to assess the impact of the compulsory licensing (CL ) policy issued by Thailand’s Ministry of Public Health during December 2006 to January 2008 on antiretroviral drugs - efavirenz and lopinavir/ritonavir combination, an oral antiplatelet agent - clopidogrel, and four anti-cancer drugs - imatinib, erlotinib, letrozole, and doceta

This review aims to access state of the art and results from economic evaluation of interventions to control and prevent influenza pandemics in order to support policy-makers with resource allocation choices, and identify gaps for future research.210-204-2553

214-351-2553

The objectives of this study are to identify resources used for providing tetravalent dengue vaccine to prevent dengue infection in the Thai health care settingestimate the budget impact of dengue vaccination program nationwide and to conduct economic evaluation of providing tetravalent dengue vaccine program compared with no vaccination program. T

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

Refractive error is a main cause of visual impairment and blindness around the world. Active screening to identify children with uncorrected refractive error and treating them throught the provision of spectacles is recommend in many countries. However, it is not clear what the best screening stratergy is. Therefore, this study focus on development

การผ่าตัดปอดที่ทำในปัจจุบันคือ วิธีมาตรฐานแบบดั้งเดิม และวิธีการใช้อุปกรณ์ตัดปอด (parenchymal stapler) ช่วยในการผ่าตัด โดยวิธีมาตรฐานแ

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement

Imatinib, the first tyrosine kinase inhibitor (TKI) has been used widely as a first-line treatment for newly diagnosed CML patients. Approximately 20-30% of CML patients are resistant or intolerant to the drug, and half of these cases are due to a gene mutation in the ABL domain. Recently, second generation TKIs have emerged, such as dasatinib and

This project aims to provide policy makers evidences for regulating an appropriate iodine supplement for pregnant women in Thailand. Due to the concern of low IQ of Thai children, there is an agreement among stakeholders that it should start promote sufficient iodine intake since gestation period. This study comprised of systematic literature revie